Biocon's FY14 revenues up 16%; set for US ANDA filings
This article was originally published in Scrip
Executive Summary
Biocon reported a 16% growth in revenues to INR29.33bn ($480m) for the year ended March 2014 backed by "broad-based business momentum", amid indications that the firm was on course to initiating dossier filings in the US in the current fiscal.